Xylazine Adulteration of the Heroin–Fentanyl Drug Supply
Annals of Internal Medicine · 2023-10 · 176 (10) · 1370-1376
DOI: 10.7326/m23-2001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Internal Medicine, 2023-10. Verfasst von Joseph D'Orazio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cooper University Healthcare, Camden, New Jersey (J.D., R.H.). Hauptthemen laut MEDLINE: Illicit Drugs, Drug Overdose. Die Arbeit wurde bisher 136-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cooper University Healthcare, Camden, New Jersey (J.D., R.H.).
- Rutgers New Jersey Medical School, Newark, New Jersey (L.N.).
- University of Pennsylvania, Philadelphia, Pennsylvania (J.P.).
- Alpert Medical School of Brown University, Providence, Rhode Island (R.W.).
ORCID-Profile: Joseph D'Orazio, Lewis Nelson, Rachel Wightman
Zitieren
APA
D'Orazio, J., Nelson, L., Perrone, J., Wightman, R., & Haroz, R. (2023). Xylazine Adulteration of the Heroin–Fentanyl Drug Supply. Annals of Internal Medicine, 176(10), 1370-1376. https://doi.org/10.7326/m23-2001
Vancouver
D'Orazio J, Nelson L, Perrone J, Wightman R, Haroz R. Xylazine Adulteration of the Heroin–Fentanyl Drug Supply. Annals of Internal Medicine. 2023;176(10):1370-1376. doi:10.7326/m23-2001
BibTeX
@article{DOrazio2023,
author = {D'Orazio, Joseph and Nelson, Lewis and Perrone, Jeanmarie and Wightman, Rachel and Haroz, Rachel},
title = {Xylazine Adulteration of the Heroin–Fentanyl Drug Supply},
journal = {Annals of Internal Medicine},
year = {2023},
volume = {176},
number = {10},
pages = {1370--1376},
doi = {10.7326/m23-2001}
}
EUVIMED